Skip to content

CIT GROUP INC: 10-Q filed 2017-11-03

What CIT GROUP INC reported in its quarterly report filed 2017-11-03 (fiscal Q3 2017): 26 published measures, 76 facts as tagged in accession 0001628280-17-010885.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-03
Fiscal period
fiscal Q3 2017
Accession
0001628280-17-010885 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CIT GROUP INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3049,335,500,000USD
At 2016-12-3164,170,200,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-3041,884,200,000USD
At 2016-12-3154,167,100,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-302,961,400,000USD
At 2016-12-316,375,200,000USD
At 2016-09-306,586,700,000USD
At 2015-12-317,470,600,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30219,600,000USD92
2017-01-01 to 2017-09-30556,200,000USD273
2016-07-01 to 2016-09-30131,500,000USD92
2016-01-01 to 2016-09-30294,500,000USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30388,700,000USD273
2016-01-01 to 2016-09-301,439,200,000USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-13,462,900,000USD273
2016-01-01 to 2016-09-30-1,889,200,000USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-309,645,200,000USD273
2016-01-01 to 2016-09-30-431,600,000USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-302,025,800,000USD
At 2016-12-311,553,000,000USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-01 to 2017-09-30133,916,000shares92
2017-01-01 to 2017-09-30172,682,000shares273
2016-07-01 to 2016-09-30202,036,000shares92
2016-01-01 to 2016-09-30201,775,000shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-01 to 2017-09-30136,126,000shares92
2017-01-01 to 2017-09-30174,201,000shares273
2016-07-01 to 2016-09-30202,755,000shares92
2016-01-01 to 2016-09-30202,388,000shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-01 to 2017-09-301.64USD/shares92
2017-01-01 to 2017-09-303.22USD/shares273
2016-07-01 to 2016-09-300.65USD/shares92
2016-01-01 to 2016-09-301.46USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-01 to 2017-09-301.61USD/shares92
2017-01-01 to 2017-09-303.19USD/shares273
2016-07-01 to 2016-09-300.65USD/shares92
2016-01-01 to 2016-09-301.46USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-119,800,000USD92
2017-01-01 to 2017-09-30-95,500,000USD273
2016-07-01 to 2016-09-3054,500,000USD92
2016-01-01 to 2016-09-30210,100,000USD274

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-30176,700,000USD92
2017-01-01 to 2017-09-30549,000,000USD273
2016-07-01 to 2016-09-30188,200,000USD92
2016-01-01 to 2016-09-30574,800,000USD274

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2017-09-30625,500,000USD
At 2016-12-31685,400,000USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2017-01-01 to 2017-09-303,425,500,000USD273
2016-01-01 to 2016-09-300USD274

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-30277,300,000USD92
2017-01-01 to 2017-09-30884,500,000USD273
2016-07-01 to 2016-09-30302,900,000USD92
2016-01-01 to 2016-09-30942,300,000USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-30131,370,803shares
At 2016-12-31202,087,672shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-09-308,787,100,000USD
At 2016-12-318,765,800,000USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-09-30-73,300,000USD
At 2016-12-31-140,100,000USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-09-307,451,300,000USD
At 2016-12-3110,003,100,000USD
At 2016-09-3011,204,900,000USD
At 2015-12-3110,945,200,000USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2017-09-308,531,200,000USD
At 2016-12-3114,935,500,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-30103,000,000USD92
2017-01-01 to 2017-09-30246,700,000USD273
2016-07-01 to 2016-09-30148,700,000USD92
2016-01-01 to 2016-09-30453,300,000USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-07-01 to 2017-09-30234,700,000USD92
2017-01-01 to 2017-09-30623,000,000USD273
2016-07-01 to 2016-09-30135,000,000USD92
2016-01-01 to 2016-09-30332,400,000USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-01-01 to 2017-09-30600,000USD273
2016-01-01 to 2016-09-30136,400,000USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-38,000,000USD273
2016-01-01 to 2016-09-3049,900,000USD274

Inspect the source

Entity
CIT GROUP INC / CIK 0001171825
Captured
SEC response SHA-256
cb16a4f77a441ed68a775915c8b0bfbb0930e9c215aa22fb538201368b73650c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001171825.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))